Literature DB >> 2935154

Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure.

N Katsube, D Schwartz, P Needleman.   

Abstract

Vasopressin, its 1-deamino analog (dAVP), angiotensin II, and phenylephrine, administered intravenously, increased plasma atriopeptin immunoreactivity in chloral hydrate-anesthetized rats. A continuous one hour infusion of either dAVP or phenylephrine caused a sustained elevation in: a) systemic blood pressure; b) right atrial pressure; c) left ventricular end diastolic pressure; and d) plasma atriopeptin immunoreactivity. While continuous infusion of angiotensin II also produced a sustained elevation in left ventricular end diastolic pressure, the changes in right atrial pressure and plasma atriopeptin were only transient. These data suggest that plasma atriopeptin most closely correlates with right atrial pressure. Consistent with this hypothesis, we found that the release of atriopeptin directly correlated with changes in right atrial pressure in anesthetized, water-immersed rats.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935154     DOI: 10.1016/0006-291x(85)91226-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure.

Authors:  H Meyer-Lehnert; T Bayer; H G Predel; K Glänzer; H J Kramer
Journal:  Klin Wochenschr       Date:  1991-11-26

Review 2.  The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.

Authors:  A M Richards
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

3.  Is atriopeptin a physiological or pathophysiological substance? Studies in the autoimmune rat.

Authors:  J E Greenwald; M Sakata; M L Michener; S D Sides; P Needleman
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

4.  Responsiveness of the ANP providing system to volume load in conscious dogs.

Authors:  Y Nishida; A Miyata; H Morita; N Uemura; K Kangawa; H Matsuo; H Hosomi
Journal:  Pflugers Arch       Date:  1988-10       Impact factor: 3.657

5.  Paradoxical relationship between atriopeptin plasma levels and diuresis-natriuresis induced by acute volume expansion.

Authors:  M Sakata; J E Greenwald; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

6.  Renal effects of TAPP, a highly selective mu-opioid agonist.

Authors:  J Gutkowska; P W Schiller
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 7.  Interactions between atrial natriuretic factor and the autonomic nervous system.

Authors:  C C Lang; A D Struthers
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

8.  Mechanisms underlying chemoreceptor inhibition induced by atrial natriuretic peptide in rabbit carotid body.

Authors:  W J Wang; L He; J Chen; B Dinger; S Fidone
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

9.  Atrial natriuretic peptide release due to physical exercise in healthy persons and in cardiac patients.

Authors:  D H Petzl; E Hartter; W Osterode; H Böhm; W Woloszczuk
Journal:  Klin Wochenschr       Date:  1987-02-16

Review 10.  Atrial natriuretic peptide in the central nervous system of the rat.

Authors:  G Skofitsch; D M Jacobowitz
Journal:  Cell Mol Neurobiol       Date:  1988-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.